Mass General Brigham Study Adds More Evidence That Gen AI Still Fumbles Differential Diagnosis
A new study highlighted by Fierce Healthcare found that general AI chatbots continue to struggle with differential diagnoses. The finding reinforces a growing consensus that broad medical fluency does not equal dependable diagnostic reasoning.
Differential diagnosis is where many AI health claims run into reality. It requires not just recognizing a condition, but ranking possibilities, revising assumptions, and doing so with incomplete clinical data.
The Mass General Brigham findings matter because they speak to a basic mismatch between chatbot design and clinical work. These systems are optimized to produce fluent, helpful-seeming text. Diagnosis, by contrast, depends on uncertainty management, not conversational confidence.
This should temper enthusiasm for deploying generalist models as early diagnostic assistants without substantial guardrails. In a low-data consultation, a convincing answer can be more dangerous than an obviously wrong one because it may suppress further questioning.
The broader market implication is that healthcare AI needs deeper specialization. Vendors will increasingly be judged not by whether their models can talk like clinicians, but by whether they can support clinicians in the hard cases where the diagnosis is not obvious.